Sr Associate Scientist, Analytical Operations

For Current Kite Pharma Employees and Contractors: Please log onto your Internal Career Site to apply for this job. At Kite we believe every employee deserves a great leader. As a people leader now or in the future, we expect that you will model and create an environment of inclusion, be intentionally focused on the hiring, development, growth and retention of talent, and empower teams to align and achieve goals. Job Description Job Overview Product Attribute Sciences is seeking a talented and highly motivated Sr Associate Scientist with a background in immunology, cell biology, and/or cancer biology. The ideal candidate will have expertise with high-throughput molecular techniques to assess immune cell function using various platforms and technologies, e.g. genomics, transcriptomics and proteomics. In addition, the successful candidate will have experience in cell-surface profiling to assess the functional phenotype of immune cells. The AS will perform innovative characterization studies to interrogate quality attributes of Kite’s cell therapy products. The SAS will collaborate cross-functionally with Process Design, Research, Translational Medicine, and/or Quality teams in an effort to enable in-process attribute and product understanding. The ideal candidate should be adaptable and willing to accept new roles and responsibilities that could evolve over time. Responsibilities include but are not limited to: Design and execution of novel and innovative characterization studies using both cell-based assays and high-throughput molecular and cellular techniques to interrogate immune cell biology and function Handling and maintenance of associated materials, such as cells and reagents, in an established and controlled manner Generation, analysis, interpretation, documentation and presentation of experimental data Author, review, and edit technical documents, i.e. SOPs and/or reports Requirements: M.S. in Biology, Immunology or related discipline with 4 years of industry experience, or B.S. in Biology, Immunology or related discipline with 6 years of industry experience Additional Qualifications: Experience with high throughput single-cell molecular techniques including, but not limited to, 10X Genomics , Tapestri, BD Rhapsody, and/or Nanostring platforms Experience and technical understanding of ELISA, MSD, Luminex-based assays, Incucyte, and/or ddPCR Experience in cell-surface profiling using CyTOF mass cytometry, 40 color flow cytometry, cell sorting, and/or ImageStream cell imaging is a plus Experience with cell culture (aseptic techniques, human cell line expansion); experience with human primary cell culture and isolation of immune cells from multiple tissues is preferred. Proficient in the use of Microsoft Office, data analysis software (Prism, JMP) and other applications Strong scientific writing and presentation skills Ability to think critically and demonstrate troubleshooting and problem-solving skills Highly collaborative with excellent interpersonal, verbal and written communication skills Self-motivated, detail-oriented, and willing to accept temporary responsibilities outside of initial job description Comfortable in a fast-paced environment The salary range for this position is: $117,725.00 - $152,350.00. Kite considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. Benefits include company-sponsored medical, dental, vision, and life insurance plans*. For additional benefits information, visit: https://www.gilead.com/careers/compensation-benefits-and-wellbeing * Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans. Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma. For jobs in the United States: As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact careers@gilead.com for assistance. Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Kite has made the decision to require all U.S., Canada, Australia, Singapore, and Hong Kong employees and contractors to receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation. For more information about equal employment opportunity protections, please view the 'Know Your Rights' poster. NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT PAY TRANSPARENCY NONDISCRIMINATION PROVISION Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team. Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion. For Current Kite Pharma Employees and Contractors: Please log onto your Internal Career Site to apply for this job. Change The World With Us Everyone at Kite is grounded by one common goal – curing cancer. Every day, we aim to establish a direct line between that purpose and our day-to-day work. We are creating Kite together, with the recognition that the best teams are built by the best people. We maintain an attitude of curiosity, and creativity with each challenge as we develop a new market for cancer therapies. We appreciate and respect one another, and most importantly, we don’t take success for granted. While we’ve come a long way to make what others viewed as impossible, possible, we know one thing is certain. Today is just the beginning. Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Kite has made the decision to require all U.S., Canada, Australia, Singapore, and Hong Kong employees and contractors to be fully vaccinated against COVID-19 as a condition of employment. The health of our employees, contractors, their loved ones, our partners and the communities and people we serve is a top priority. Vaccination is the most effective way currently available to deliver on that priority. The purpose of the vaccination requirement is to minimize the spread of COVID-19 in the workplace and support the health and safety of our communities. A person is considered fully vaccinated two weeks after the second dose of a two-dose vaccine or two weeks after a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request an accommodation.